Related Experiment Video
Updated: Jun 24, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with
Masaki Shiota1, Hiroto Izumi, Akihide Tanimoto
1Department of Molecular Biology, School of Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Japan.
Abstract:
Programmed cell death protein 4 (PDCD4) has recently been shown to be involved in both transcription and translation, and to regulate cell growth. However, the mechanisms underlying PDCD4 function are not well understood. In this study, we show that PDCD4 interacts directly with the transcription factor Twist1 and leads to reduced cell growth through the down-regulation of the Twist1 target gene Y-box binding protein-1 (YB-1). PDCD4 interacts with the DNA binding domain of Twist1, inhibiting its DNA binding ability and YB-1 expression. Immunohistochemical analysis showed that an inverse correlation between nuclear PDCD4 and YB-1 expression levels was observed in 37 clinical prostate cancer specimens. Growth suppression by PDCD4 expression was completely recovered by either Twist1 or YB-1 expression. Moreover, PDCD4-overexpressing cells are sensitive to cisplatin and paclitaxel but not to etoposide or 5-fluorouracil. In summary, PDCD4 negatively regulates YB-1 expression via its interaction with Twist1 and is involved in cancer cell growth and chemoresistance.
Insights
Programmed cell death protein 4 (PDCD4) inhibits cancer cell growth by down-regulating Y-box binding protein-1 (YB-1) through interaction with the transcription factor Twist1. PDCD4 influences chemoresistance, impacting cancer treatment strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Programmed cell death protein 4 (PDCD4) is implicated in cell growth regulation, but its precise mechanisms remain unclear.
- Understanding PDCD4's role in transcription and translation is crucial for cancer therapy development.
Purpose of the Study:
- To elucidate the molecular mechanisms by which PDCD4 regulates cell growth.
- To investigate the interaction between PDCD4, Twist1, and its target gene YB-1.
- To assess the impact of PDCD4 on cancer cell chemoresistance.
Main Methods:
- Investigated the direct interaction between PDCD4 and the transcription factor Twist1.
- Analyzed the effect of PDCD4 on Twist1 DNA binding and YB-1 expression.
- Conducted immunohistochemical analysis on clinical prostate cancer specimens.
- Evaluated the sensitivity of PDCD4-overexpressing cells to various chemotherapeutic agents.
Main Results:
- PDCD4 directly binds to the DNA binding domain of Twist1, inhibiting its activity and down-regulating YB-1 expression.
- An inverse correlation between nuclear PDCD4 and YB-1 levels was observed in prostate cancer tissues.
- PDCD4-mediated growth suppression was reversed by increased Twist1 or YB-1 expression.
- PDCD4 overexpression enhanced sensitivity to cisplatin and paclitaxel, but not etoposide or 5-fluorouracil.
Conclusions:
- PDCD4 negatively regulates YB-1 expression through interaction with Twist1, impacting cancer cell proliferation.
- PDCD4 plays a significant role in modulating cancer cell chemoresistance.
- These findings offer potential therapeutic targets for cancer treatment by modulating PDCD4-Twist1-YB-1 signaling.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Canonical Wnt Signaling Pathway

